Results 31 to 40 of about 42,942 (233)

CLINICAL SIGNIFICANCE OF BIOMARKERS IN OVARIAN CANCER, PROSTATE CANCER, COLORECTAL CANCER

open access: yesИсследования и практика в медицине, 2016
The review is devoted to modern notions about serum tumor markers and their place in oncology: using for differential diagnosis, in prognosis of course of tumor process, during follow-up, for preclinical detection of disease recurrences, as well as in ...
N. V. Marshutina   +3 more
doaj   +1 more source

Tuberculous peritonitis with elevated serum CA125 levels mimicking peritoneal cancer

open access: yesClinical and Experimental Obstetrics & Gynecology, 2020
Background: Tuberculosis can spread to the peritoneum through the gastrointestinal tract via mesenteric lymph nodes or directly from the blood, lymph, or fallopian tubes.
A. Taniwaki   +7 more
doaj   +1 more source

Low expression of miR-27b in serum exosomes of non-small cell lung cancer facilitates its progression by affecting EGFR

open access: yesOpen Medicine, 2022
Non-small cell lung cancer (NSCLC) is a malignant tumor. Serum exosomal miR-27b is related to tumor diagnosis. We explored the roles of serum exosomal miR-27b in NSCLC. NSCLC patients were assigned to NSCLC-early/terminal groups, with healthy subjects as
Cao Xiying   +4 more
doaj   +1 more source

Activity profile of the CA125 antigen towards human red blood cells [PDF]

open access: yes, 2010
Starting from the mucin nature of the CA125 antigen and conditions associated with high serum concentrations, this study is an attempt to gain insight into its activity profile towards human erythrocytes.
Janković Miroslava, Mitić N.
core   +1 more source

Prevalence of K-RAS mutations and CA125 tumor marker in patients with ovarian carcinoma

open access: yesCaspian Journal of Internal Medicine, 2020
Background: Ovarian carcinoma is one of the leading causes of cancer-related death among females. K-ras codon 12 mutations are commonly occurring mutations in different types of cancers and leads to resistance against anti-EGFR therapeutics.
Nazanin Bagherlou   +4 more
doaj  

Epigenetics in ovarian cancer: premise, properties, and perspectives. [PDF]

open access: yes, 2018
Malignant ovarian tumors bear the highest mortality rate among all gynecological cancers. Both late tumor diagnosis and tolerance to available chemical therapy increase patient mortality.
Huang, Shuang   +16 more
core   +2 more sources

Survivin and VEGF as novel biomarkers in diagnosis of endometriosis [PDF]

open access: yesJournal of Medical Biochemistry, 2016
Background: The aim of this study was to investigate the role of peripheral blood markers as additional diagnostic tools to transvaginal ultrasound (TVU) findings in the diagnosis of endometriosis.
Aćimović Milena   +6 more
doaj  

Predictive value of CA 125 and CA 72-4 in ovarian borderline tumors [PDF]

open access: yes, 2009
Background: The aim of this study was to assess the prognostic value of cancer antigen (CA) 125 and CA 72-4 in patients with ovarian borderline tumor (BOT).
Burges, Alexander   +8 more
core   +1 more source

Effects of GnRH Agonist and Dienogest in Combination on HE4 and CA125 Levels in Patients with Adenomyosis and Adenomyoma: A Prospective Cohort Study

open access: yesClinical and Experimental Obstetrics & Gynecology, 2023
Background: The traditional pathology of adenomyosis (AM) suggests that this is a common benign uterine disease. Hysterectomy is the gold standard of care and is viewed as a decisive treatment for AM; however, more conservative treatment approaches are ...
DongGe Wang   +3 more
doaj   +1 more source

A case of abdominal sarcoidosis in a patient with acute myeloid leukemia. [PDF]

open access: yes, 2013
The allogeneic bone marrow transplantation usually preceded by induction chemotherapy, in fit patients, represents the gold standard in the acute myeloid leukaemia.
Addeo, Alfredo   +4 more
core   +2 more sources

Home - About - Disclaimer - Privacy